SASA POLYESTER SANAYİ A.Ş.

Share Issue/Capital Change • Nov 15, 2022

Summary Info	Board Resolution on Conditional Capital Increase and CMB Application
Update Notification Flag	No
Correction Notification Flag	No
Postponed Notification Flag	No

Board Decision Date	15.11.2022
Authorized Capital (TL)	3.000.000.000
Paid-in Capital (TL)	2.255.830.245
Target Capital (TL)	2.263.633.096

Rights Issue (Allocated)

Share Group Info	Paid-in Capital (TL)	Amount of Private Placement Through Capital Increase By Restraining Preemptive Rights (TL)	Proportion of Private Placement Through Capital Increase By Restraining Preemptive Rights To The Capital (%)	New Shares'' ISIN	Form	Amount of Shares Cancelled (TL)
SASA, TRASASAW91E4	2.255.830.245	7.802.851	0,34589	SASA, TRASASAW91E4	Registered

	Paid-in Capital (TL)	Amount of Private Placement Through Capital Increase By Restraining Preemptive Rights (TL)	Proportion of Private Placement Through Capital Increase By Restraining Preemptive Rights To The Capital (%)	Amount of Shares Cancelled (TL)
TOTAL	2.255.830.245	7.802.851,000	0,34589

The Person Increased Capital Devoted	Paya Dönüştürülebilir Tahvil Sahipleri

Other Aspects To Be Notified

Capital Market Board Application Date	15.11.2022

Additional Explanations

At our company's Board of Directors Meeting held on 15 November 2022 ( today), the following issues were resolved:

-To meet the demands of the Convertible Bond (CB) holders who request to exercise their conversion rights in October 2022 by realizing a conditional capital increase;

-To calculate the shares to be given to the CB holders who demand to exercise their conversion rights for a total principal bond amount of EUR 13,900,000 over the conversion price of EUR 0.017814 per share and the conversion rate of 5,613,562.37 per EUR 100.000 principal amount of the bonds;

-To increase the issued capital of the company from TRY 2,255,830,245 to TRY 2,263,633,096 by the conversion amount of TRY 7,802,851 ;

-To restrict the preemptive rights completely for the conditional capital increase and to allocate all of the new shares to be issued to the CB holders who demand to exercise their conversion rights in October 2022 .

In this context, an application was made to the Capital Markets Board on 15 November 2022 in order to get permission for the capital increase and approval of the issuance document.

In the event of any discrepancy between the Turkish and English versions of this disclosure statement, the original Turkish version shall prevail. SASA disclaims all warranties and makes no representations about the accuracy or completeness of the English translation and assumes no liability for any errors, omissions or inaccuracies that may arise from use of this translation.